Factors controlling the turnover of T memory cells

Immunological Reviews

Volumn 156, Issue , 1997, Pages 79-85

  Sprent, Jonathan ^a   Tough, David F ^a   Sun, Siquan ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; HERMES ANTIGEN; INTERFERON;

CELL CYCLE; CELL DIFFERENTIATION; CELL SURVIVAL; MEMORY CELL; NONHUMAN; PHENOTYPE; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS;

EID: 0030949555     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb00960.x     Document Type: Review

References (57)

1. Cerottini J-C, MacDonald HR. The cellular basis of T-cell memory. Annu Rev Immunol 1989;7:77-89.
2. Gray D. Immunological memory. Annu Rev Immunol 1993;11:49-77.
3. MacKay CR. Immunological memory. Adv Immunol 1993;53:217-265.
4. Sprent J. T and B memory cells. Cell 1994;76:315-322.
5. Zinkernagel RM, Bachmann MF, Kundig TE, Oehen S, Pirchet H, Hengartner H. On immunological memory. Annu Rev Immunol 1996;14:333-368.
6. Sprent J. Lifespans of naive, memory and effector lymphocytes. Curr Opin Immunol 1993;5:433-438.
7. Sprent J, Webb SR. Intrathymic and extrathymic clonal deletion of T cells. Curr Opin Immunol 1995;7:196-205.
8. Sprent J. Immunological memory. The Immunologist 1995;3:212-215.
9. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
10. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm EA. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992;140:197-205.
11. Korsmeyer SJ. Bcl-2: A repressor of lymphocyte death. Immunol Today 1992;13:285-288.
12. Akbar AN, et al. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 1993;178:427-438.
13. L. Immunity 1995;3:87-98.
14. Cory S. Regulation of lymphocyte survival by the blc-2 gene family. Annu Rev Immunol 1995;13:513-544.
15. McHeyzer-Williams MG, Davis MM. Antigen-specific development of primary and memory T cells in vivo. Science 1995;268:106-111.
16. Feldbush TL. Antigen modulation of the immune response. The decline of immunological memory in the absence of continuing antigenic stimulation. Cell Immunol 1973;8:435-444.
17. Gray D, Skarvall H. B cell memory is short-lived in the absence of antigen. Nature 1988;336:70-72.
18. Gray D, Matzinger P. T cell memory is short-lived in the absence of antigen. J Exp Med 1991;174:969-974.
19. Oehen S, Waldner H, Kundig TM, Hengartner H, Zinkernagel RM. Antivirally protective cytotoxic T cell memory lymphocytic choriomeningitis virus is governed by persisting antigen. J Exp Med 1992;176:1273-1281.
20. MacLennan ICM. Germinal centers. Annu Rev Immunol 1994;12:117-139.
21. Di Rosa F, Matzinger P. Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells. J Exp Med 1996;183:2153-2163.
22. Beverley PCL. Is T cell memory maintained by cross-reactive stimulation? Immunol Today 1990;11:203-205.
23. Mullbacher A. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J Exp Med 1994;179:317-321.
24. + T cell memory determined by clonal burst size. Nature 1994;369:652-644.
25. Lau LL, Jamieson BD, Somasundaram R, Ahmed R. Cytotoxic T cell memory without antigen. Nature 1994;369:648-652.
26. Budd RC, et al. Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigen stimulation. J Immunol 1987;138:3120-3129.
27. Sanders ME, Makgoba MW, Shaw S. Human naive and memory T cells. Immunol Today 1988;9:195-199.
28. Hathcock KS, et al. Expression of variable exon A-, B-, C-specific CD45 determinants on peripheral and thymic T cell populations. J Immunol 1992;148:19-28.
29. Swain SL, Bradley LM. Helper T cell memory: more questions than answers. Semin Immunol 1992;4:59-68.
30. Beverley PCL. Functional analysis of human T cell subsets defined by CD45 isoform expression. Semin Immunol 1992;4:35-41.
31. + T memory cells. J Immunol 1995;154:5870-5875.
32. Bell EB, Sparshott SM. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 1990;348:163-166.
33. + T cells are hyperreactive to antigenic challenge in vitro. J Exp Med 1996;184:2141-2151.
34. + memory T cells in virus-infected hosts. J Exp Med 1996;183:1367-1375.
35. + T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11, MEL-14 expression. J Immunol 1993;151:575-587.
36. von Boehmer H, Hafen K. The life span of naive α/β T cells in secondary lymphoid organs. J Exp Med 1993;177:891-896.
37. Sprent J, Schaefer M, Hurd M, Surh CD, Ron Y. Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J Exp Med 1991;174:717-728.
38. Tough DF, Sprent J. Turnover of naive- and memory-phenotype T cells. J Exp Med 1994;179:1127-1135.
39. Scollay R, Godfrey DI. Thymic emigration: conveyor belts or lucky dips? Immunol Today 1995;16:268-273.
40. a antigens: long term progeny of dividing cells include cells with a naive phenotype. J Immunol 1996;156:48-55.
41. Buchmeier MJ, Welsh RM, Dutko FJ. Oldstone MBA. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol 1980;30:275-331.
42. Razvi ES, Welsh RM. Apoptosis in viral infections. Adv Virus Res 1995;45:1-60.
43. Tough DF, Borrow P, Sprent J. Induction of bystander T-cell proliferation by viruses and type I interferon in vivo. Science 1996;272:1947-1950.
44. Dumont FJ, Coker LZ. Interferon-α/β enhances the expression of Ly-6 antigens on T cells in vivo and in vitro. Eur J Immunol 1986;16:735-740.
45. Kirchner H. Interferons, a group of multiple lymphokines. Springer Semin Immunopathol 1984;7:347-374.
46. Biron CA, Gazzinelli RT. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr Opin Immunol 1995;7:485-496.
47. Krieg AM, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546-549.
48. Pisetsky DS. Immune activation by bacterial DNA: a new genetic code. Immunity 1996;5:303-310.
49. + T cells: implications for tumor immunotherapy. Immunity 1996;4:555-564.
50. Bird AP, Taggart MH. Variable patterns of total DNA and rDNA methylation in animals. Nucleic Acid Res 1980;8:1485-1497.
51. Warren HS, Vogel FR, Chedid LA. Current status of immunological adjuvants. Annu Rev Immunol 1986;4:369-388.
52. + cell subsets. J Exp Med 1993;178:1637-1644.
53. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994;1:327-339.
54. Louis JA, Chiller JM, Weigle WO. The ability of bacterial lipopolysaccharide to modulate the induction of unresponsiveness to a state of immunity: cellular parameters. J Exp Med 1973;138:1481-1495.
55. Yamamoto S, Kuramoto E, Shimada S, Tokunaga T. In vitro augmentation of natural killer cell activity and production of interferon-α/β and -γ with deoxyribonucleic acid fraction from mycobacterium bovis BCG. Jpn J Cancer Res 1988;79:866-873.
56. Corr M, Lee DJ, Carson DA, Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 1996;184:1555-1560.
57. Sata Y, et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996;273:352-354.